Lv1
28 积分 2023-04-11 加入
Retagliptin as add‐on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial
3天前
已完结
Efficacy and safety of cofrogliptin once every 2 weeks in Chinese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, phase 3 trial
3天前
已完结
Retagliptin as add‐on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial
30天前
已完结
Fatty liver index increases the risk of sudden cardiac arrest in cardiovascular disease–free adults
1个月前
已关闭
Long-Term Glycemic Control and the Risk of Liver Stiffness Progression and Liver-Related Events in MASLD
1个月前
已完结
Association between longitudinal weight change and clinical outcome in individuals with MASLD
1个月前
已完结
Dual elastography ultrasound for classifying metabolic dysfunction-associated steatotic liver disease: a cross-sectional study within a prospective cohort
1个月前
已完结
Treatment Options and Continuity of Care in Metabolic-associated Fatty Liver Disease: A Multidisciplinary Approach
1个月前
已完结
USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPARγ
1个月前
已完结
Effects of diabetes distress on glycemic level and health-related quality of life among patients with type 2 diabetes mellitus: A cross-sectional study
1个月前
已完结